Acetyl-L-carnitine attenuates Poly I:C-induced sickness behavior in mice

Biosci Biotechnol Biochem. 2022 Sep 23;86(10):1423-1430. doi: 10.1093/bbb/zbac132.

Abstract

Fatigue is accompanied by a decrease in physical activity or malaise, and might be reduced by acetyl-L-carnitine (ALC) administration. The purpose of this study was to investigate the preventive effects of ALC on Poly I:C-induced sickness behavior in mice. For the experiment, male C3H/HeN mice were used and treated with ALC for 5 days before Poly I:C administration. ALC administration attenuated the decrease in wheel behavior activity of mice at 24 h after Poly I:C administration and ALC-treated mice quickly recovered from the sickness behavior. The gene expression of brain-derived neurotrophic factor (BDNF) in the cerebrum and hippocampus, which is associated with physical activity, was higher in the ALC-treated group. Translocator protein 18kDa (TSPO), which has cytoprotective effects, was up-regulated in the cerebrum and hippocampus, suggesting that ALC suppressed the decrease in activity induced by Poly I:C treatment through enhancement of cytoprotective effects in the brain.

Keywords: BDNF; RAW264.7; TSPO; microglia; wheel running.

MeSH terms

  • Acetylcarnitine* / pharmacology
  • Acetylcarnitine* / therapeutic use
  • Animals
  • Brain-Derived Neurotrophic Factor* / genetics
  • Brain-Derived Neurotrophic Factor* / metabolism
  • Illness Behavior
  • Male
  • Mice
  • Mice, Inbred C3H
  • Poly I-C / pharmacology

Substances

  • Brain-Derived Neurotrophic Factor
  • Acetylcarnitine
  • Poly I-C